📰 Contract Development News
Page 33 - Contract Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Development. Real-time updates on events, politics, business and more.
June 8, 2023
Explore the need for reliable cell-based assays in therapeutic bispecific antibody development in immuno-oncology
June 8, 2023
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a... | June 8, 2023
June 8, 2023
The global Lyophilized Injectable Market is expected to grow at a steady 5.8% over the next few years. In 2023, the lyophilized injectable market is expected to be worth $3043.55 million. Demand for lyophilized injectables is expected to reach a peak of US$ 5348.56 Mn by 2033.Because of their stability at room tempe...
June 7, 2023
Explore the need for reliable cell-based assays in therapeutic bispecific antibody development in immuno-oncology
June 6, 2023
/PRNewswire/ -- What is the Overview of Cell and Gene Therapy CDMO Market? Cell and gene therapies (CAGT) are used in treating various diseases like heart...
June 6, 2023
New state-of-the-art manufacturing equipment to double overall prostaglandin capacity of the Budapest site by 2027EUROAPI is the only Western supplier with a complete portfolio of prostaglandins and a fully integrated production site located in EuropeReduction of environmental footprint thanks to solar panels and mo...
June 2, 2023
Summit Pharmaceuticals International (Head Office: Chiyoda-ku, Tokyo; Chief Executive Officer: Katsuya Okuyama; hereinafter "SPI") has signed an exclusive distributorship agreement in Japan with EVERZOM
June 2, 2023
Clean hydrogen, championed by Andrew Cottone, president and ceo of ADESIS, aims to position delaware at the forefront of clean energy.
June 1, 2023
Laxxon Medical to participate in 2023 BIO International Convention New York, 06/01/2023 / 08:02, EST/EDT - EQS Newswire - Laxxon Medical NEW YORK, NY / ACCESSWIRE / June 1, 2023 / Laxxon Medical, a pharmatechnology company whose novel platform technology offers unparalleled drug delivery advance...
May 31, 2023
NEW YORK, NY / ACCESSWIRE / May 31, 2023 / Laxxon Medical, a leading 3D screen printing pharmatechnology company, announced today the establishment of its Scientific Advisory Board (SAB), which is comprised